Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CalciMedica (CALC)
NASDAQ:CALC
CalciMedica (CALC) Stock Price & Analysis
230 Followers
CALC Stock Chart & Stats
Day’s Range$5.74 - $5.99
52-Week Range― - ―
Previous Close$6
Volume5.71K
Average Volume (3M)N/A
Market Cap
$63.48M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 13, 2024EPS Estimate
-$0.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$18.67Price Target Upside213.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
CalciMedica News
PremiumCompany Announcements
CalciMedica Advances Auxora in Kidney Injury Trial
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CALC FAQ
What was CalciMedica’s price range in the past 12 months?
Currently, no data Available
What is CalciMedica’s market cap?
Currently, no data Available
When is CalciMedica’s upcoming earnings report date?
CalciMedica’s upcoming earnings report date is May 13, 2024 which is in 9 days.
How were CalciMedica’s earnings last quarter?
CalciMedica released its earnings results on Mar 28, 2024. The company reported -$0.72 earnings per share for the quarter, beating the consensus estimate of -$0.872 by $0.152.
Is CalciMedica overvalued?
According to Wall Street analysts CalciMedica’s price is currently Undervalued.
Does CalciMedica pay dividends?
CalciMedica does not currently pay dividends.
What is CalciMedica’s EPS estimate?
CalciMedica’s EPS estimate is -$0.67.
How many shares outstanding does CalciMedica have?
Currently, no data Available
What happened to CalciMedica’s price movement after its last earnings report?
CalciMedica reported an EPS of -$0.72 in its last earnings report, beating expectations of -$0.872. Following the earnings report the stock price went down -0.716%.
Which hedge fund is a major shareholder of CalciMedica?
Among the largest hedge funds holding CalciMedica’s share is Deerfield Management Company, LP. It holds CalciMedica’s shares valued at N/A.
---
CalciMedica Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.67 (213.78% Upside)
$18.67 (213.78% Upside)
Hedge Fund Trend
Decreased
By 265.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $15.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 66.1%
Last 30 Days ▲ 66.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
57.89%
12-Months-Change
Fundamentals
Return on Equity
-155.72%
Trailing 12-Months
Asset Growth
-69.28%
Trailing 12-Months
Company Description
CalciMedica
Graybug Vision Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve.
---
CALC Stock 12 Months Forecast
Average Price Target
$18.67
▲(213.78% Upside)
Technical Analysis
Best Analysts Covering CALC
1 Year
1 Year Success Rate
4/5 ratings generated profit
1 Year Average Return
+51.18%
reiterated a buy rating 9 days ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +51.18% per trade.
---